Blog

In the Castor D&I interview series, Castorian women in technology share their experiences and thoughts on making the workplace more inclusive.

Castor’s most significant core value is “Achieve anything with a happy and healthy Team,” and so we wanted to ensure we embrace this value even more in a remote-first set-up where employees are not regularly coming into a shared working space.

COVID-19 changed the conversation around enrollment and recruitment for clinical trials. Learn how eConsent is helping researchers do more despite restrictions.

Hoboken, New Jersey: December 17, 2020: Castor, a leading provider of clinical trial technology, today announced the launch…

In September 2020, Castor CEO Derk Arts, MD, Ph.D., led a webinar on electronic informed consent (eConsent) challenges…

Industry veterans from leading life sciences companies including Johnson & Johnson, Biogen, and Medtronic, will support the Company’s…

In the wake of Brexit, medical device companies secure a UKCA mark as proof of conformity to place their device on the UK market. Learn what this means for your organization and how to prepare.

Though technologies that support decentralized clinical trials (DCT) have been readily available for years, meaningful industry adoption has…

Patient reported outcome measures in clinical trials have traditionally been done on paper. Surveys are a common way…

User Acceptance Testing (UAT) is a critical component in the clinical trial process. Its primary goal is to…